Cormorant Private Healthcare Fund Ii, Lp - Net Worth and Insider Trading
Cormorant Private Healthcare Fund Ii, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cormorant Private Healthcare Fund Ii, Lp owns 13 companies in total, including Akouos Inc (AKUS) , Avidity Biosciences Inc (RNA) , and Atea Pharmaceuticals Inc (AVIR) among others .
Insider Ownership Summary of Cormorant Private Healthcare Fund Ii, Lp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AKUS | Akouos Inc | 2020-06-25 | 10 percent owner |
RNA | Avidity Biosciences Inc | 2020-06-11 | 10 percent owner |
AVIR | Atea Pharmaceuticals Inc | 2020-10-29 | 10 percent owner |
2021-04-22 | 10 percent owner | ||
2020-11-18 | 10 percent owner | ||
2022-12-20 | director | ||
2021-06-29 | 10 percent owner | ||
2021-03-25 | 10 percent owner | ||
2021-06-23 | 10 percent owner | ||
2020-12-15 | 10 percent owner | ||
2023-05-29 | other: See below | ||
2023-05-29 | other: See below | ||
2023-10-02 | 10 percent owner |
Cormorant Private Healthcare Fund Ii, Lp Trading Performance
Cormorant Private Healthcare Fund Ii, Lp Ownership Network
Cormorant Private Healthcare Fund Ii, Lp Owned Company Details
What does Akouos Inc do?
Who are the key executives at Akouos Inc?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .
Akouos Inc (AKUS) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Akouos Inc (AKUS). Other recent insider transactions involving Akouos Inc (AKUS) include a net purchase of 29,992,668 shares made by Kearny Acquisition Corp ,
In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 29,992,668 shares were bought by its insiders, resulting in a net purchase of 29,992,668 shares.
Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akouos Inc Insider Transactions
- Download to Excel(.xls)
What does Avidity Biosciences Inc do?
Who are the key executives at Avidity Biosciences Inc?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of Avidity Biosciences Inc. Other key executives at Avidity Biosciences Inc include Chief Scientific Officer Arthur A Levin , Chief Financial Officer Michael F Maclean , and director & President and CEO Sarah Boyce .
Avidity Biosciences Inc (RNA) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Avidity Biosciences Inc (RNA). Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 124,600 shares made by Arthur A Levin , a net sale of 223,092 shares made by Sarah Boyce , and a net sale of 116,616 shares made by Michael F Maclean .
In summary, during the past 3 months, insiders sold 345,641 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 345,641 shares. During the past 18 months, 470,502 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 470,502 shares.
Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avidity Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Atea Pharmaceuticals Inc do?
Who are the key executives at Atea Pharmaceuticals Inc?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of Atea Pharmaceuticals Inc. Other key executives at Atea Pharmaceuticals Inc include See Remarks Andrea Corcoran , See Remarks Wayne Foster , and director & 10 percent owner & President & CEO & and Chairman Jean-pierre Sommadossi .
Atea Pharmaceuticals Inc (AVIR) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 56,910 shares made by Jean-pierre Sommadossi , a net sale of 15,870 shares made by Maria Arantxa Horga , and a net sale of 15,843 shares made by Andrea Corcoran .
In summary, during the past 3 months, insiders sold 0 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,948 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 126,948 shares.
Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atea Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Partners Lp .
Rain Oncology Inc (RAIN) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , and a net sale of 995,000 shares made by Boxer Capital, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 1,372,418 shares were bought by its insiders, resulting in a net purchase of 203,445 shares.
Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include director & Chief Technology Officer Cyrus Harmon , 10 percent owner Paradigm Biocapital Advisors Lp , and director & President and CEO Sean Bohen .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 283,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 8,742 shares made by Kovacs Shane William Charles .
In summary, during the past 3 months, insiders sold 65,000 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 65,000 shares. During the past 18 months, 418,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,255,932 shares were bought by its insiders, resulting in a net purchase of 1,837,858 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
- Download to Excel(.xls)
What does Erasca Inc do?
Who are the key executives at Erasca Inc?
Cormorant Private Healthcare Fund Ii, Lp is the director of Erasca Inc. Other key executives at Erasca Inc include director & 10 percent owner & See Remarks Jonathan E Lim , Chief Medical Officer Shannon Morris , and General Counsel Ebun Garner .
Erasca Inc (ERAS) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Erasca Inc (ERAS). Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,300,000 shares made by Jonathan E Lim , a net purchase of 150,000 shares made by Alexander W. Casdin , and a net purchase of 615,384 shares made by Bihua Chen .
In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 80,000 shares, with a net purchase of 80,000 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 3,105,384 shares were bought by its insiders, resulting in a net purchase of 3,105,384 shares.
Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Erasca Inc Insider Transactions
- Download to Excel(.xls)
What does Aerovate Therapeutics Inc do?
Who are the key executives at Aerovate Therapeutics Inc?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of Aerovate Therapeutics Inc. Other key executives at Aerovate Therapeutics Inc include Chief Medical Officer Hunter Gillies , director & Chief Executive Officer Timothy P Noyes , and SENIOR VICE PRESIDENT & CMC Marinus Verwijs .
Aerovate Therapeutics Inc (AVTE) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Aerovate Therapeutics Inc (AVTE). Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 235,587 shares made by Benjamin T Dake , a net sale of 153,142 shares made by Timothy P Noyes , and a net sale of 62,255 shares made by Hunter Gillies .
In summary, during the past 3 months, insiders sold 208,525 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 208,525 shares. During the past 18 months, 610,473 shares of Aerovate Therapeutics Inc (AVTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 610,473 shares.
Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerovate Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Design Therapeutics Inc do?
Who are the key executives at Design Therapeutics Inc?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of Design Therapeutics Inc. Other key executives at Design Therapeutics Inc include director & President and CEO Joao Md Siffert , director & 10 percent owner Simeon George , and 10 percent owner Sr One Capital Fund I Aggregator Lp .
Design Therapeutics Inc (DSGN) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Design Therapeutics Inc (DSGN). Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net purchase of 36,000 shares made by Rodney W Lappe , a net purchase of 2,235,000 shares made by Arsani William , and a net purchase of 900,000 shares made by Sr One Capital Fund I Aggregator Lp .
In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 28,265 shares, with a net purchase of 28,265 shares. During the past 18 months, 0 shares of Design Therapeutics Inc (DSGN) were sold and 4,118,715 shares were bought by its insiders, resulting in a net purchase of 4,118,715 shares.
Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Design Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Monte Rosa Therapeutics Inc do?
Who are the key executives at Monte Rosa Therapeutics Inc?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of Monte Rosa Therapeutics Inc. Other key executives at Monte Rosa Therapeutics Inc include Principal Accounting Officer Edmund Dunn , General Counsel Philip Nickson , and Chief Business Officer Julian G Jones .
Monte Rosa Therapeutics Inc (GLUE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monte Rosa Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does BioAtla Inc do?
Who are the key executives at BioAtla Inc?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of BioAtla Inc. Other key executives at BioAtla Inc include director & 10 percent owner & Chief Executive Officer Short Jay M Phd , See Remarks Christian Vasquez , and director & President Scott Andrew Smith .
BioAtla Inc (BCAB) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in BioAtla Inc (BCAB). Other recent insider transactions involving BioAtla Inc (BCAB) include a net purchase of 13,700 shares made by Sylvia Mcbrinn , a net purchase of 90,800 shares made by Short Jay M Phd , and a net purchase of 27,495 shares made by Christian Vasquez .
In summary, during the past 3 months, insiders sold 0 shares of BioAtla Inc (BCAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioAtla Inc (BCAB) were sold and 151,995 shares were bought by its insiders, resulting in a net purchase of 151,995 shares.
BioAtla Inc (BCAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioAtla Inc Insider Transactions
- Download to Excel(.xls)
What does GreenLight Biosciences Holdings PBC do?
Who are the key executives at GreenLight Biosciences Holdings PBC?
Cormorant Private Healthcare Fund Ii, Lp is the other: See below of GreenLight Biosciences Holdings PBC. Other key executives at GreenLight Biosciences Holdings PBC include director & President & CEO Juan Andrey Zarur , other: Member of 10% owner group Marta Ortega-valle , and other: Member of 13D Group Montealegre Lacayo Jaime Javier .
GreenLight Biosciences Holdings PBC (GRNA) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in GreenLight Biosciences Holdings PBC (GRNA). Other recent insider transactions involving GreenLight Biosciences Holdings PBC (GRNA) include a net sale of 9,188,659 shares made by Cormorant Global Healthcare Master Fund, Lp ,
In summary, during the past 3 months, insiders sold 0 shares of GreenLight Biosciences Holdings PBC (GRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,188,659 shares of GreenLight Biosciences Holdings PBC (GRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,188,659 shares.
GreenLight Biosciences Holdings PBC (GRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
GreenLight Biosciences Holdings PBC Insider Transactions
- Download to Excel(.xls)
What does Environmental Impact Acquisition Corp do?
Who are the key executives at Environmental Impact Acquisition Corp?
Cormorant Private Healthcare Fund Ii, Lp is the other: See below of Environmental Impact Acquisition Corp. Other key executives at Environmental Impact Acquisition Corp include director & President & CEO Juan Andrey Zarur , other: Member of 10% owner group Marta Ortega-valle , and other: Member of 13D Group Montealegre Lacayo Jaime Javier .
Environmental Impact Acquisition Corp (ENVIU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Environmental Impact Acquisition Corp (ENVIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Environmental Impact Acquisition Corp (ENVIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Environmental Impact Acquisition Corp (ENVIU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Environmental Impact Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does MoonLake Immunotherapeutics do?
Who are the key executives at MoonLake Immunotherapeutics?
Cormorant Private Healthcare Fund Ii, Lp is the 10 percent owner of MoonLake Immunotherapeutics. Other key executives at MoonLake Immunotherapeutics include director & Chief Executive Officer Santos Da Silva Jorge , Chief Scientific Officer Kristian Reich , and Chief Financial Officer Matthias Bodenstedt .
MoonLake Immunotherapeutics (MLTX) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 1,629,151 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .
In summary, during the past 3 months, insiders sold 242,537 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 242,537 shares. During the past 18 months, 484,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 1,629,151 shares were bought by its insiders, resulting in a net purchase of 1,144,411 shares.
MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MoonLake Immunotherapeutics Insider Transactions
- Download to Excel(.xls)
Cormorant Private Healthcare Fund Ii, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Cormorant Private Healthcare Fund Ii, Lp. You might contact Cormorant Private Healthcare Fund Ii, Lp via mailing address: 200 Clarendon Street, 52nd Floor, Boston Ma 02116.
Discussions on Cormorant Private Healthcare Fund Ii, Lp
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey